| Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. | None |
| Function of the c-Myc oncoprotein. | None |
| c-myc and bcl-2 Expression in supraglottic squamous cell carcinoma of the larynx. | None |
| Transcriptional activation of c-myc proto-oncogene by WT1 protein. | None |
| Results show that cyclin-dependent kinase 4 (CDK4) mediates the proliferative and oncogenic activities of Myc in vivo through a mechanism that involves the sequestration of specific CDK inhibitors. | None |
| NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter. | None |
| Acquisition of responsiveness to chemical carcinogens by rodent embryo fibroblasts expressing high levels of the c-myc proto-oncogene. | None |
| The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. | None |
| Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. | None |
| Cooperative induction of rat mammary cancer by radiation and 1-methyl-1-nitrosourea via the oncogenic pathways involving c-Myc activation and H-ras mutation. | None |
| Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization. | None |
| This paper reports the first solution structure of a G-quadruplex found to form in the promoter region of an oncogene (c-MYC). | None |
| Backbone assignment of the dimerization and DNA-binding domain of the oncogenic transcription factor v-Myc in complex with its authentic binding partner Max. | None |
| What determines the instability of c-myc proto-oncogene mRNA?. | None |
| Comparison of the effect of ELF on c-myc oncogene expression in normal and transformed human cells. | None |
| Tissue microarray analysis of C-MYC oncogene copy number changes in larynx carcinoma. | None |
| [Expression and significance of TERT and c-Myc oncogene protein product on cholesteatoma epithelium]. | None |
| Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins. | None |
| MYC family genes might affect oncogenesis through distinct sets of targets, in particular implicating the importance of transcriptional repression | None |
| Increased expression of c-myc proto-oncogene in biopsies of ulcerative colitis and Crohn s colitis. | None |